Hb FS hemoglobin

asymmetric hemoglobin hybrid FS (alpha2gammabetaS) inhibits hemoglobin S (Hb S) polymerization in vitro and underlies the protective effect of fetal hemoglobin (Hb F) in homozygous sickle cell disease

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Davies, S C: 1 article (11/2001)
2.	Green, B N: 1 article (11/2001)
3.	Layton, D M: 1 article (11/2001)
4.	Nicolaides, K H: 1 article (11/2001)
5.	Ofori-Acquah, S F: 1 article (11/2001)
6.	Serjeant, G R: 1 article (11/2001)

Related Diseases

1.

Sickle Cell Anemia (Hemoglobin S Disease) 11/01/2001 - "Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS (alpha2gammabetaS) in sickle cell disease." 11/01/2001 - "Formation of the asymmetric hemoglobin hybrid FS (alpha2gammabetaS) inhibits hemoglobin S (Hb S) polymerization in vitro and underlies the protective effect of fetal hemoglobin (Hb F) in homozygous sickle cell disease. "

Related Drugs and Biologics

1.	Hemoglobins (Hemoglobin)
2.	Sickle Hemoglobin
3.	Fetal Hemoglobin (Hemoglobin F)